Literature DB >> 23904182

A step toward development of printable dosage forms for poorly soluble drugs.

Dhara Raijada1, Natalja Genina, Daniela Fors, Erik Wisaeus, Jouko Peltonen, Jukka Rantanen, Niklas Sandler.   

Abstract

The purpose of this study was to formulate printable dosage forms for a poorly soluble drug (piroxicam; PRX) and to gain understanding of critical parameters to be considered during development of such dosage forms. Liquid formulations of PRX were printed on edible paper using piezoelectric inkjet printing (PIJ) and impression printing (flexography). The printed dosage forms were characterized using scanning electron microscopy with energy dispersive X-ray spectroscopy (SEM-EDX) and the amount of drug was determined using high-performance liquid chromatography. Solutions of PRX in polyethylene glycol 400 (PEG-400):ethanol (40:60) and in PEG-400 were found to be optimal formulations for PIJ and flexography, respectively. SEM-EDX analysis revealed no visible solid particles on the printed dosage forms indicating the drug most likely remained in solution after printing. More accurate drug deposition was obtained by PIJ as compared with flexography. More than 90% drug release was achieved within 5 min regardless of printing method used. The solubility of drug in solvents/cosolvents, rheological properties of formulations, properties of substrate, feasibility and accuracy of the printing methods, and detection limit of analytical techniques for characterization of printed dosage forms are some of the concerns that need to be addressed for development of printable dosage forms of poorly soluble drugs.
© 2013 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  SEM-EDX; flexography; formulation; inkjet printing; microscopy; oral drug delivery; personalized medicine; physical characterization; poorly water-soluble drugs; preformulation

Mesh:

Substances:

Year:  2013        PMID: 23904182     DOI: 10.1002/jps.23678

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

Review 1.  Printing Methods in the Production of Orodispersible Films.

Authors:  Maram Suresh Gupta; Tegginamath Pramod Kumar; Robert Davidson; Guruprasad Rao Kuppu; Kamla Pathak; Devegowda Vishakante Gowda
Journal:  AAPS PharmSciTech       Date:  2021-04-09       Impact factor: 3.246

Review 2.  Emergence of 3D Printed Dosage Forms: Opportunities and Challenges.

Authors:  Mohamed A Alhnan; Tochukwu C Okwuosa; Muzna Sadia; Ka-Wai Wan; Waqar Ahmed; Basel Arafat
Journal:  Pharm Res       Date:  2016-05-18       Impact factor: 4.200

3.  Visualization and Non-Destructive Quantification of Inkjet-Printed Pharmaceuticals on Different Substrates Using Raman Spectroscopy and Raman Chemical Imaging.

Authors:  Magnus Edinger; Daniel Bar-Shalom; Jukka Rantanen; Natalja Genina
Journal:  Pharm Res       Date:  2017-03-01       Impact factor: 4.200

Review 4.  Polymers in Technologies of Additive and Inkjet Printing of Dosage Formulations.

Authors:  Evgenia V Blynskaya; Sergey V Tishkov; Konstantin V Alekseev; Alexandre A Vetcher; Anna I Marakhova; Dovlet T Rejepov
Journal:  Polymers (Basel)       Date:  2022-06-22       Impact factor: 4.967

5.  Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy.

Authors:  Tochukwu C Okwuosa; Beatriz C Pereira; Basel Arafat; Milena Cieszynska; Abdullah Isreb; Mohamed A Alhnan
Journal:  Pharm Res       Date:  2016-12-09       Impact factor: 4.200

6.  Three-dimensional drugs: A new era in the pharmaceutical development.

Authors:  Harish Kumar; Ajay Prakash; Phulen Sarma; Bikash Medhi
Journal:  Indian J Pharmacol       Date:  2017 Nov-Dec       Impact factor: 1.200

7.  Development of Nanosuspension Formulations Compatible with Inkjet Printing for the Convenient and Precise Dispensing of Poorly Soluble Drugs.

Authors:  Dennis H Leung
Journal:  Pharmaceutics       Date:  2022-02-19       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.